Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: J Hosp Med. 2023 Aug 22;18(10):896–907. doi: 10.1002/jhm.13193

Table 2.

Incidence of Perceived Barriers to Initiating Buprenorphine and Methadone for OUD in the Hospital

Barriera Buprenorphine (n, %) Methadone (n, %)
Unsure of the legality of prescribing this medication 58 (36.3) 53 (33.1)
Don’t have time in my day to initiate this medication 32 (20.0) 27 (16.9)
Don’t know how to initiate this medication 87 (54.4) 96 (60.0)
Don’t feel like our patients are interested in this medication 10 (6.3) 12 (7.5)
Don’t feel like our patients will be able to successfully maintain sobriety 18 (11.3) 18 (11.3)
No clear pathway or workflows to initiate this medication in our hospital 72 (45.0) 85 (53.1)
No clear plan for post discharge treatment linkage for this medication 84 (52.5) 89 (55.6)
Other (open-ended section) 12 (7.5) 10 (6.3)
None of the above are concerns 22 (13.8) 22 (13.8)
a

Participants could choose multiple answers